You can buy or sell PRAX and other stocks, options, and ETFs commission-free!
Praxis Precision Medicines, Inc. Common Stock, also called Praxis Precision Medicines, is a clinical-stage genetic neuroscience company that develops therapies for patients and families affected by complex and debilitating brain disorders. The company was founded by Kiran Reddy, David Goldstein and Steven Petrou on September 22, 2015 and is headquartered in Cambridge, MA. The listed name for PRAX is Praxis Precision Medicines, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Feb 5, Pre-Market